作者:
Luisier,R. [1]
;
Lempi?inen,H. [2]
;
Scherbichler,N. [3]
;
Braeuning,A. [4]
;
Geissler,M. [5]
;
Dubost,V. [6]
;
Müller,A. [7]
;
Scheer,N. [8]
;
Chibout,S.-D. [9]
;
Hara,H. ;
Picard,F. ;
Theil,D. ;
Couttet,P. ;
Vitobello,A. ;
Grenet,O. ;
Grasl-Kraupp,B. ;
Ellinger-Ziegelbauer,H. ;
Thomson,J.P. ;
Meehan,R.R. ;
Elcombe,C.R. ;
Henderson,C.J. ;
Wolf,C.R. ;
Schwarz,M. ;
Moulin,P. ;
Terranova,R. ;
Moggs,J.G.
作者单位:
DMPK, Novartis Institutes for Biomedical Research, CH-4057 Basel, Switzerland
[1]
Medical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1
[2]
Preclinical Safety, Novartis Institutes for Biomedical Research, CH-4057 Basel, Switzerland
[3]
Institute of Cancer Research, University of Vienna, 1090 Vienna, Austria
[4]
TaconicArtemis, Neurather Ring 1, K?ln 51063, Germany
[5]
Department of Investigational Toxicology, Bayer Pharma AG, 42096 Wuppertal, Germany
[6]
Department of Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology
[7]
MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
[8]
CXR Biosciences Ltd, 2 James Lindsay Place, Dundee DD1 5JJ, United Kingdom
[9]
发布时间
2014-09-04